Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gliclazide Responsiveness in T2DM with KCNJ11/ABCC8 Haplotype
NCT02201602Phase 4Completed
- Sponsor
- Khoo Teck Puat Hospital
- Start
- Aug 2014
- Primary completion
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of gliclazide in type 2 diabetes mellitus (T2DM), sponsored by Khoo Teck Puat Hospital. Started Aug 2014; status: completed.
02
Drugs
gliclazide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02201602.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02201602.